Concepedia

Guy Peachey

GP

13

Publications

1.2K

Citations

13

H-Index

2009

Active since

Affiliations

Novartis (United Kingdom)(Current)

Novartis (Switzerland)

Sint Franciscus Gasthuis

Novartis (United States)

GlaxoSmithKline (United States)

Guy Peachey is an author at Novartis (United Kingdom) specializing in allergy, medicine, and asthma.

Top concepts

Publications per year

2009–2023

13

Publications

13

Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy

Valeria Ricotti, Deborah Ridout, E. Scott et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 255 citations

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

Laurie A. Lee, Zelie Bailes, Neil Barnes et al. · The Lancet Respiratory Medicine · 2020 · 239 citations · Full text

, , +5

The eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma

Gert‐Jan Braunstahl, C.-W. Chen, Robert Maykut et al. · Respiratory Medicine · 2013 · 195 citations · Full text

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma

Jean Bousquet, Zenon Siergiejko, Ewa Świebocka et al. · Allergy · 2011 · 166 citations

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

Zenon Siergiejko, Ewa Świebocka, Nicola J. Smith et al. · Current Medical Research and Opinion · 2011 · 86 citations

Rows per page

1–5 of 13